Particulars |
|
|
|
Company Name
| Concord Drugs Ltd
| Year End
| 202503
|
Full Year |
Equity (₹ Cr.) |
10.00 |
B.V. (₹) |
34.10 |
Sales(₹ Cr.) |
36.93 |
NP (₹ Cr.) |
0.30 |
NP Var (%) |
-29.00 |
Div% |
0.00 |
CPS(₹) |
1.70 |
EPS (₹) |
0.30 |
Traded Value(₹ Lakhs) |
97.19 |
52 Week High |
42.00 |
52 Week Low |
26.00 |
Price BSE |
41.00 |
Price NSE |
0.00 |
Market Capital (₹ Cr.) |
41.23 |
P/C Ratio |
23.90 |
P/E Ratio |
138.70 |
Price Vs.BV |
1.20 |
|
Latest Quarter |
Year End |
202503 |
Sales (₹ Cr.) |
7.96 |
NP(₹ Cr.) |
0.01 |
NP Var % |
102.00 |
Trailing Twelve Months |
Year End |
202503 |
Sales |
45.28 |
OPM |
5.02 |
NP |
-0.53 |
NP Var (%) |
-29.49 |
EPS |
0.30 |
PE |
137.43 |
|
|